In the present study and those of others, TLR4 antagonist, TAK-242 was effective in prevention of UVB-induced skin cancer in animal models and pave the way for clinical trials in which TAK-242 is evaluated for prevention of UV-induced skin cancer. Here, TLR4 is linked to skin neoplasm.